January 30, 2019
Immunogenicity of GSKs’ MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age
Read More
January 30, 2019
Immunogenicity of GSKs’ MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age
Read More
January 30, 2019
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures
Read More
December 10, 2018
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals’ Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age
Read More
X